Alpha-Lipoic Acid (ALA)

Service Description

Alpha-Lipoic Acid (ALA) IV is a focused, provider-guided infusion designed to support antioxidant defense, metabolic function, and overall cellular performance. ALA is a powerful, vitamin-like antioxidant that plays a central role in cellular energy pathways and oxidative balance. Its unique ability to function in both water- and fat-based environments allows it to support whole-body cellular processes, making it a targeted option for those seeking metabolic and neurological support. This infusion is intentionally administered as a standalone treatment to maintain compatibility, precision, and optimal effectiveness. **What’s Inside** IV Hydration Base Provides fluid support and serves as the delivery medium for the ALA infusion. Primary Nutrient * Alpha-Lipoic Acid (ALA) to support antioxidant activity, metabolic pathways, and cellular function --- **Available Dosing Options** Dosing is selected based on provider guidance, individual tolerance, and wellness goals: * 100 mg – Foundational support, often used for first-time clients * 200–300 mg – Expanded antioxidant and metabolic support * 400–500 mg – Advanced cellular and neurological support * 600 mg – Intensive antioxidant and metabolic optimization --- **Why Choose ALA IV** * Supports antioxidant defense and oxidative balance * Promotes metabolic efficiency and cellular energy pathways * Supports mental clarity and neurological function * Offers a focused, precision-based infusion without additional additives --- **Administration & Customization** ALA is administered intravenously as a standalone infusion. Final dosing, infusion rate, and protocol are determined by a licensed medical provider based on individual needs and clinical assessment. --- **Important Information** Clinical screening is required prior to treatment. This service is subject to provider approval. Not all therapies are appropriate for every individual. This service is intended to support overall wellness and is not a substitute for medical care.